Back to Baker Bros. Advisors LP Baker Bros. Advisors LP

RYTMRYTM

Showing 8 of 30 quarters

Position history for Baker Bros. Advisors LPBaker Bros. Advisors LP's holdings in Rhythm Pharmaceuticals, Inc.

Yes. Baker Bros. Advisors holds 5,604,483 shares of RYTM (Rhythm Pharmaceuticals), worth $622.3M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Baker Bros. Advisors has held RYTM in every 13F on record since Q1 2019, 30 quarterly filings. RYTM is 3.1% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

$622.3M

Current Shares

5.6M

Total Value Change

+$287.1M

Total Shares Change

-793,883

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.6M
0.0%
$622.3M3.1%$111.03
0
2026-Q1
Unchanged
5.6M
0.0%
$487.4M2.8%$86.97
0
2025-Q4
Unchanged
5.6M
0.0%
$599.9M3.5%$107.04
0
2025-Q3
Unchanged
5.6M
0.0%
$566M4.1%$100.99
0
2025-Q2
Unchanged
5.6M
0.0%
$354.1M3.4%$63.19
0
2025-Q1
Decreased
5.6M
-7.9%
$296.9M3.3%$52.97
0
2024-Q4
Decreased
6.1M
-4.9%
$340.6M3.6%$55.98
0
2024-Q3
Increased
6.4M
0.0%
$335.2M3.5%$52.39
57

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used